Virios Therapeutics, Inc. - VIRI
About Gravity Analytica
Recent News
- 02.03.2026 - International Association for the Study of Pain (IASP) World Congress 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – The Safety of IMC‑1 in Patients With Fibromyalgia: Phase 2a Study Results
- 02.03.2026 - EULAR European Congress of Rheumatology 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – IMC‑1, a Fixed Dose Combination of Famciclovir and Celecoxib, Improves Common Symptoms Associated With Fibromyalgia in Addition to Pain: Post Hoc Analysis of a Phase 2a Trial
- 02.03.2026 - Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study
- 02.02.2026 - Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
- 02.02.2026 - Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
- 01.27.2026 - EULAR European Congress of Rheumatology 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – IMC‑1, a Fixed Dose Combination of Famciclovir and Celecoxib, Improves Common Symptoms Associated With Fibromyalgia in Addition to Pain: Post Hoc Analysis of a Phase 2a Trial
- 01.27.2026 - Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study
- 01.27.2026 - International Association for the Study of Pain (IASP) World Congress 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – The Safety of IMC‑1 in Patients With Fibromyalgia: Phase 2a Study Results
- 01.21.2026 - EULAR European Congress of Rheumatology 2021 Poster Presentation - William Pridgen, MD; Carol Duffy, PhD; Judy F. Gendreau, MD; R. Michael Gendreau, MD, PhD – IMC‑1, a Fixed Dose Combination of Famciclovir and Celecoxib, Improves Common Symptoms Associated With Fibromyalgia in Addition to Pain: Post Hoc Analysis of a Phase 2a Trial
- 01.21.2026 - Digestive Disease Week® (DDW) 2021 Presentation – Carol Duffy, PhD; William Pridgen, MD – Active Herpes Simplex Virus Type 1 Infection of the Gastric Mucosa is Associated with Functional Gastrointestinal Disorders: A Pilot Case-Control Study